Aflibercept 100mg
- Brand Names: EYLEA®, Zaltrap
- Form: Single-dose vials for intravenous or intravitreal use
- Strength: 100 mg/4 mL (25 mg/mL) S
- Manufacturer: Sanofi‑Aventis
- Country: Germany/Mexico/India
- MOQ: 10 Vials
- Shelf Life: 24 Months
- Storage: 2–8 °C; protect from light; do not freeze
Description
Indications & Use: Intravitreal 2 mg injection for wet AMD, DME, DR, RVO, ROP; IV 100 mg/4 mL with FOLFIRI for metastatic colorectal cancer. Aflibercept is being researched for its potential to inhibit angiogenesis in VEGF-expressing breast cancers, particularly triple-negative breast cancer, through targeted delivery of anti-VEGF therapy.
